A twelve-person biotech running its first trial has no leadership bench. It has a VP of Clinical Development, possibly a clinical operations director, and a CRO. That structure gets a Phase 1 study executed. It does not survive the transition to a multi-study program.

The failure point is predictable. When the second and third studies start…

Most leadership advice assumes a stable operating environment. Clinical research does not offer one. A clinical operations leader manages a program whose timeline is governed by enrollment behavior they cannot control, whose quality standards are set by regulators they do not report to, and whose execution runs through vendors who work for a different employer.

That combination produces a leadership problem with no clean corporate analogue. The clinical project leader carries accountability for…